Table 3.
Reference | Type of treatment | Composition | Model | Dose | Intake | Duration | Parameters analyzed | Conclusion |
---|---|---|---|---|---|---|---|---|
Cui et al. 2021 | Polysaccharide from Scutellaria baicalensis Georgi, SP2-1 | Mannose, ribose, rhamnose, glucuronic acid, glucose, xylose, arabinose, fucose Colitis inducer: 3% dextran sodium sulfate (DSS) |
C57BL/6J mice | 50 and 200 mg/kg | Once-daily | 10 days | r body weight, loose stools, morbidity, and hematochezia. The disease activity index (DA Evaluated body weight, loose stools, morbidity, hematochezia, and the disease activity index |
Effective (attenuated body weight loss, reduced DAI, ameliorated colonic pathological damage, and decreased MPO activity) |
Kanwal et al. 2020 | Dictyophora indusiate polysaccharide (DIP) | Glucose 59.84%, mannose 23.55%, and galactose 12.95% Colitis inducer: dextran sodium sulfate (DSS) |
low dose 10 mg/kg and (high dose 33 mg/kg | Once-daily | 2 weeks | Assessment of disease activity index, histological, analysis of goblet cells and mucus layer thickness, cytokines by ELISA and Immunoblotting assay | Effective | |
Sakena et al. 2020 | Gracilaria fisheri oligosaccharides (GFO) | monosaccharide composition in the GFO was D-galactose. Colitis inducer: acetic acid (AA)-induced colitis mice |
100, 500, or 1000 mg/kg | Once-daily | 2 weeks | Gastrointestinal (GI) transit time, ex vivo propulsive motility, in vitro colonic smooth muscle contractility, the composition of colonic microbiota, and production of SCFAs | Effective (prevent and attenuate colitis symptoms and GI dysmotility & reducing populations of harmful bacteria and increasing SCFAs | |
Li et al. 2020 | Freeze-dried muscadine grapes (FMG) or dealcoholized muscadine wine (DMW) | FMG: Fructose 34.7 %Glucose 31 %, sucrose 9.9% DMW: Fructose, sucrose, and glucose not detected Colitis inducer: 3% dextran sodium sulfate (DSS) |
C57BL/6J mice | FMG (7%, w/w) or DMW (5.5%, v/w) | NM | 3 weeks | Bodyweight, stool consistency and bleeding, Disease activity index (DAI), short-chain fatty acids in feces, and Mucin 2 and IgA in feces | Effective (Reduced dysbiosis in the colon.) |
Li et al. 2020 | CYP-1 (Chinese yam polysaccharide) | CYP-1, mannoglucan of 1,4-α-linked Glcp branched at O-2, O-3, and O-6 position by t-α-linked Map Colitis inducer: dextran sodium sulfate (DSS) | 300 mg/kg body weight | Once-daily | 1 week | Histological, measurement of cytokines, gut microbiota analysis, and colonic transcriptomic | Effective | |
Liu et al. 2020 | α-D-glucan from marine fungus Phoma herbarum YS4108 | Polysaccharide with backbone possessed most likely a linear α-(1 → 4) bonded glucopyranose main chain co-bearing through side α-(1 → 6) | Male C57BL/6 mice | 40 mg/kg/day | Once-daily | 1 week | Disease activity index (DAI) scores, histology immunohistochemistry analysis, evaluation of SOD and MDA activities, and determinations of inflammatory cytokines | Effective (significantly increased butyrate, isovaleric acid levels, and prominent alterations on specific microbiota) |
Gou et al. 2019 | WPSPP-1 | Glucose and mannose in the molar ratio of 20.44:1.00 |
400 mg/kg body weight | NM | 4 weeks | Histological, gut microbiota, and biochemical analysis | Effective | |
Xie et al. 2019 | Ganoderma lucidum polysaccharide (GLP) | β-glucan (>90%) that contained a 1,6-linked β-D-Glcp backbone | male Wistar rats | NM | NM | 3 weeks | Determination of the disease activity index, body weight, short-chain fatty acids in cecal samples, | Effective (immunity enhancement, inflammatory response alleviation & colon cancer risk reduction) |
Zha et al. 2020 | xylan butyrate ester, Xylo |
xylose, arabinose, and glucose at a ratio of 1:5:1 | C57BL/6 mice | 50 and 200 mg/kg | NM | 2 weeks | body weights, feces, and physical activity of the mice, Compositional analysis of the gut microbiota, | Effective (reduces inflammatory intestinal damage) |
Liu et al. 2016 | konjac oligosaccharide (KOS) | Glucose and mannose residues at a molar ratio of 1:1.6 joined through the β1,4-glucosidic link Colitis inducer: 2,4,6-trinitrobenzenesulfonic acid (TNBS) |
1 g and 4 g/kg | Once-daily | 2 weeks | Bacteria profile, short-chain fatty acids (SCFAs) production in feces, colon damage by macroscopic and histological | Effective | |
de Albuquerque et al. 2010 | Kale and papaya |
Kale (60%) + papaya (40%) Colitis inducer: tri-nitro-benzenesulfonic acid (TNBS) |
500 mg/kg per rat weight | NM | 3 weeks | Clinical endoscopic and histological scores as well as rectal mucosal expression levels of IL-10, IL-1b, TNFa and IL-8 Evaluation of the intestinal anti-inflammatory effects and microbiological studies of intestine luminal content |
Effective |